Bocunebart's PACAP-targeting mechanism positions it as a potential first-in-class therapy in a thin pipeline of novel ...

Dr. Monty Pal introduces the program by outlining the evolving treatment landscape for advanced renal cell carcinoma (RCC) ...

Prostate biopsies in Florida typically cost between $4,864 and $5,334 per procedure, representing a significant burden when a majority of procedures yield benign findings. If the study’s objectives ...

The Ann Arbor District Library's sixth annual Big Gay Read is diving into "Bury Your Gays," a darkly funny horror novel by masked author Chuck Tingle that somehow predicted the exact AI controversy ...

Precision neurostimulation leverages AI and closed-loop feedback, delivering tailored treatments for neurological disorders ...

For a child diagnosed with neuroblastoma—the most common infant cancer, occurring when early nerve cells grow out of ...

Wearable sensors remain largely underused, despite their utility in improving data collection and regulatory compliance.

BCAL Diagnostics launches BREASTEST Monitor—blood test to monitor post-treatment breast cancer recurrence; 91% sensitivity, ...

Please provide your email address to receive an email when new articles are posted on . Twenty percent of patients with chronic HBV achieved functional cure with bepirovirsen vs. 0% with placebo.

WASHINGTON (AP) — A first-of-its-kind drug for hepatitis B is letting some patients stop treatment without showing signs of the dangerous liver virus, what's called a "functional cure," researchers ...

LONDON, May 28 (Reuters) - GSK (GSK.L), opens new tab said its ‌experimental chronic hepatitis B drug helped nearly one in five patients achieve a functional cure in late-stage studies, raising hopes ...

Full results from the pivotal B-Well 1 and B-Well 2 phase 3 trials confirm that bepirovirsen delivers statistically significant functional cure rates in chronic hepatitis B. Bepirovirsen (GSK/Ionis ...